Aurisco Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Aoruite Pharmaceutical Co., Ltd. was founded in 1998, focusing on the research, development, production and sales of complex raw materials and formulations, as well as CRO/CDMO of oligonucleotide drugs. It is a continuously innovative international pharmaceutical enterprise, registered in Taizhou, Zhejiang, with an operation center in Shanghai and subsidiary companies in Yangzhou, Tianjin, and Hangzhou. The company has been deeply involved in the pharmaceutical industry for more than 20 years, continuously promoting technological innovation, and is leading in the fields of complex synthesis, synthetic biology, photochemistry, etc. in China, becoming a long-term partner of globally renowned pharmaceutical companies. A comprehensive quality system, sufficient production capacity, and a global sales network provide high-quality products and efficient services to global customers. |
| Headquarter | Taizhou |
| Establish Date | 3/5/1998 |
| Listed Code | 605116.SH |
| Listed Date | 9/21/2020 |
| Chairman | Peng Zhien. |
| CEO | Chu Dingjun. |
| Website | www.aurisco.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
